Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome

BACKGROUND: There is a need for standardized quantitative disease assessment measures in mycosis fungoides/Sézary syndrome. In 2005, a cutaneous T-cell lymphoma (CTCL)-severity index (SI) that not only measures disease extent (on a scale of 0-75) independent of the classic TNM(B) staging system but can also be used to estimate individual 5-year survival (SR5) was reported.


Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

Source: Br J Dermatol

Gniadecki R, Kragballe K, Dam TN, Skov L;

British Journal of Dermatology (Jan 2011)


Atopic Dermatitis

From Dermatology Online Journal

Abstract and Introduction

Epidemiology of Atopic Dermatitis

Etiology and Pathogenesis

Clinical Manifestations

The Characteristic Clinical Features of the Eczema of AD


The best bookmaker in the UK William Hill - William Hill
Bokmakers website.
Get free Wordpress Templates - Wordpress -